# Proteona Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/proteona-pte

- Industry: Biotechnology
- Headquarters: Singapore
- Website: www.proteona.com
- Total disclosed funding: $3.1M
- Latest round: Seed (Jan 23, 2020)
- Investors on record: 3

## About

Based in Singapore, and established in 2017, Proteona Pte. Ltd., is a biomedical company that provides single-cell analysis services for its customers. The company is a result of a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology, and Research (A*STAR). Jonathan Scolnick, Gene Yeo, and Shawn Hoon are the co-founders of the firm, and in March 2022, Xingeyuan Biotechnology Co., Ltd. acquired the firm. As of April 2022, Proteona Pte. Ltd. is being led by its CEO, Andreas Schmidt, and has operations in Singapore, Germany, and the US.

The company offers clinical sample analysis services through its proprietary platform called ESCAPE™ (enhanced single-cell analysis with protein expression), enabling pharmaceutical firms, clinicians, etc to add single-cell level precision to their projects, and thereby enhance the clinical outcomes. The firm’s platform generates both genomic and proteomic data from a single cell, identifies various biomarkers, and creates ML (Machine Learning) based models that predict therapeutic response and disease severity. Additionally, Proteona Pte. Ltd. provides AI (Artificial Intelligence) and bioinformatics-powered single-cell data analysis for its customers.

## Funding rounds

- Seed, Jan 23, 2020, $3.1M — Pix Vine Capital, SEEDS Capital, Xora Innovation

## Investors

- Pix Vine Capital (https://capitalatlas.ai/funds/pix-vine-capital) — Seed
- SEEDS Capital (https://capitalatlas.ai/funds/seeds-capital) — Seed
- Xora Innovation (https://capitalatlas.ai/funds/xora-innovation) — Seed